GLIPR1
Glioma pathogenesis-related protein 1
Also known as: GLIP1_HUMAN, GliPR, RTVP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48060
- Gene
- GLIPR1
- Ensembl
- ENSG00000139278
- Chromosome
- 12
- Canonical length
- 266 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a protein with similarity to both the pathogenesis-related protein (PR) superfamily and the cysteine-rich secretory protein (CRISP) family. Increased expression of this gene is associated with myelomocytic differentiation in macrophage and decreased expression of this gene through gene methylation is associated with prostate cancer. The protein has proapoptotic activities in prostate and bladder cancer cells. This gene is a member of a cluster on chromosome 12 containing two other similar genes. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
266 residues, UniProt reviewed canonical sequence.
>P48060|GLIPR1
1 MRVTLATIAW MVSFVSNYSH TANILPDIEN EDFIKDCVRI HNKFRSEVKP TASDMLYMTW
61 DPALAQIAKA WASNCQFSHN TRLKPPHKLH PNFTSLGENI WTGSVPIFSV SSAITNWYDE
121 IQDYDFKTRI CKKVCGHYTQ VVWADSYKVG CAVQFCPKVS GFDALSNGAH FICNYGPGGN
181 YPTWPYKRGA TCSACPNNDK CLDNLCVNRQ RDQVKRYYSV VYPGWPIYPR NRYTSLFLIV
241 NSVILILSVI ITILVQHKYP NLVLLDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLIPR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 81 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 81 nTPM
- appendix: 44 nTPM
- smooth muscle: 37 nTPM
- spleen: 34 nTPM
- urinary bladder: 33 nTPM
- gallbladder: 31 nTPM
Single-cell type
- extravillous trophoblasts: 658 nCPM
- monocytes: 390 nCPM
- neutrophils: 336 nCPM
- cdc: 295 nCPM
- hofbauer cells: 270 nCPM
- kupffer cells: 266 nCPM
Immune cell
- neutrophil: 465 nTPM
- classical monocyte: 354 nTPM
- non-classical monocyte: 267 nTPM
- total PBMC: 265 nTPM
- myeloid DC: 241 nTPM
- intermediate monocyte: 233 nTPM
Brain region
- white matter: 22 nTPM
- cerebral cortex: 15 nTPM
- thalamus: 13 nTPM
- medulla oblongata: 12 nTPM
- choroid plexus: 12 nTPM
- pons: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GLIPR1.
Disease | ImmuneIEDB
Conditions an epitope on GLIPR1 was assayed in.
- type 1 diabetes mellitus T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLIPR1 as an antibody target. Whether an autoantibody or antibody against GLIPR1 could matter depends on whether native GLIPR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLIPR1 is annotated at the cell surface, where native GLIPR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GLIPR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...